Who owns PDL BioPharma?

Key details on PDL BioPharma (Ticker: PDLI)

Who owns PDL BioPharma?

Is PDLI a good stock to own? Find out who bought PDL BioPharma, who sold PDL BioPharma (PDLI) stock, and who holds a large position in PDL BioPharma.

Fund Name Number of Shares Share Valuation As Of
First Trust Advisors 21.40M $107.65M Sept. 30, 2015
BlackRock Fund Advisors 12.44M $44.03M Dec. 31, 2015
Vanguard 11.20M $39.64M Dec. 31, 2015
Renaissance Technologies 10.35M $36.62M Dec. 31, 2015
Schroder Investment Management 8.68M $66.96M Dec. 31, 2014
Baupost 8.00M $49.60M Dec. 31, 2011
FMR 6.37M $49.20M June 30, 2013
Acadian Asset Management 6.08M $20.24M March 31, 2016
MSDC Management 5.52M $35.11M March 31, 2012
Bank of America Corporation 4.88M $37.59M Dec. 31, 2014
Gotham Asset Management 4.75M $16.81M Dec. 31, 2015
BlackRock Institutional Trust Company, N.A. 4.68M $16.58M Dec. 31, 2015
Inves 4.66M $23.53M Sept. 30, 2015
Two Sigma Advisers 4.38M $29.02M June 30, 2012
AQR Capital Management 3.61M $26.40M March 31, 2013
STATE STREET CORPORATION 3.59M $12.70M Dec. 31, 2015
Advisors Asset Management 3.41M $12.06M Dec. 31, 2015
OppenheimerFunds 3.39M $21.00M Dec. 31, 2011
Wells Fargo & Company 3.22M $24.79M Dec. 31, 2014
ARONSON JOHNSON ORTIZ 3.17M $15.96M Sept. 30, 2015
NORTHERN TRUST 3.13M $26.45M Dec. 31, 2013

Who sold PDL BioPharma?

Fund Name Date Sold Number of Shares Sold Share Valuation
First Eagle Investment Management Dec. 31, 2010 3.55M $22.12M
Paulson & Co March 31, 2008 5.40M $57.16M